Takeda Pharmaceutical Co. Ltd. (4502:TSE) Annual Income Statement ()
4502:TSE Quarterly Financials ()
Frequently Asked Questions About Takeda Pharmaceutical Co. Ltd. (4502:TSE) Stock
Takeda Pharmaceutical Co. Ltd.'s (4502:TSE) last reported annual revenue was JPY 4,263.76 Billion.
Takeda Pharmaceutical Co. Ltd.'s (4502:TSE) annual revenue growth rate based on the revenue reported in the past 5 years is : 15.25%
Takeda Pharmaceutical Co. Ltd.'s(4502:TSE) is profitable as of its last reported annual financials.
The net profit margin for Takeda Pharmaceutical Co. Ltd.'s(4502:TSE) from its laster reported year is 3.38%
The return on equity (ROE) for Takeda Pharmaceutical Co. Ltd.'s(4502:TSE) from its last reported annual financials is : 4.15%
The return on assets (ROA) for Takeda Pharmaceutical Co. Ltd.'s(4502:TSE) from its last reported annual financials is : 2.78%
The return on invested capital (ROIC) for Takeda Pharmaceutical Co. Ltd.'s(4502:TSE) from its last reported annual financials is : 2.67%
The Debt to Equity ratio for Takeda Pharmaceutical Co. Ltd.'s(4502:TSE) from its last reported annual financials is : 61.55%
The dividend yield for Takeda Pharmaceutical Co. Ltd.'s(4502:TSE) from its laster reported year is 4.75%
Takeda Pharmaceutical Co. Ltd.'s(4502:TSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4502:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
